Some patients opt for monthly sessions, depending on their desired outcome
doi: 10.3389/fphar.2021.622841 84 ChenLWangLAoWChenYLiSHuangZet al
May 13, 2025: Study Says More People Lose Weight on Zepbound Than Wegovy According to a new study that examined post-clinical trial data, people lost more weight on Zepbound than Wegovy
In my practice as a bariatric surgeon, Ive seen firsthand the advantages of GLP-1 agonists, but Ive also noticed a pattern of misuse and misunderstanding regarding their role, particularly in the treatment of morbid obesity
According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025
This means you may feel intoxicated effects more intensely, more suddenly, or for a longer duration compared to when you weren't on GLP-1 therapy